UM

Browse/Search Results:  1-9 of 9 Help

Selected(0)Clear Items/Page:    Sort:
Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis Journal article
Yu,Jie, Zhong,Bingling, Zhao,Lin, Hou,Ying, Ai,Nana, Lu,Jin Jian, Ge,Wei, Chen,Xiuping. Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis[J]. Drug Resistance Updates, 2023, 70, 100977.
Authors:  Yu,Jie;  Zhong,Bingling;  Zhao,Lin;  Hou,Ying;  Ai,Nana; et al.
Favorite | TC[WOS]:28 TC[Scopus]:29  IF:15.8/18.1 | Submit date:2023/08/03
Drug-resistance  Ferroptosis  Lung Cancer  Mam  Nqo1  
The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone Journal article
Shao, Zeyang, Wang, Heng, Ren, Haiyan, Sun, Yinxiang, Chen, Xiuping. The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone[J]. Molecules, 2023, 28(15).
Authors:  Shao, Zeyang;  Wang, Heng;  Ren, Haiyan;  Sun, Yinxiang;  Chen, Xiuping
Favorite | TC[WOS]:12 TC[Scopus]:10  IF:4.2/4.6 | Submit date:2024/01/10
cancer  napabucasin  NQO1  STAT3  
The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone Journal article
Zeyang Ahao, Heng Wang, Haiyan Ren, Yinxiang Sun, Xiuping Chen. The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone[J]. Molecules, 2023, 28(15), 5678.
Authors:  Zeyang Ahao;  Heng Wang;  Haiyan Ren;  Yinxiang Sun;  Xiuping Chen
Adobe PDF | Favorite | TC[WOS]:12 TC[Scopus]:10  IF:4.2/4.6 | Submit date:2023/08/17
Cancer  Napabucasin  Nqo1  Stat3  
Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors Necrostatin-1 (Nec-1) and 7-Cl-O-Nec-1 (Nec-1s) are potent inhibitors of NAD(P)H: Quinone oxidoreductase 1 (NQO1) Journal article
Yu, Jie, Zhong, Bingling, Zhao, Lin, Hou, Ying, Wang, Xianzhe, Chen, Xiuping. Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors Necrostatin-1 (Nec-1) and 7-Cl-O-Nec-1 (Nec-1s) are potent inhibitors of NAD(P)H: Quinone oxidoreductase 1 (NQO1)[J]. FREE RADICAL BIOLOGY AND MEDICINE, 2021, 173, 64-69.
Authors:  Yu, Jie;  Zhong, Bingling;  Zhao, Lin;  Hou, Ying;  Wang, Xianzhe; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:7.1/7.9 | Submit date:2021/12/08
Nec-1  Nec-1s  Nqo1  Ripk1  
A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis Journal article
Zhong, Bingling, Yu, Jie, Hou, Ying, Ai, Nana, Ge, Wei, Lu, Jin Jian, Chen, Xiuping. A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis[J]. Free Radical Biology and Medicine, 2021, 166, 104-115.
Authors:  Zhong, Bingling;  Yu, Jie;  Hou, Ying;  Ai, Nana;  Ge, Wei; et al.
Favorite | TC[WOS]:14 TC[Scopus]:13  IF:7.1/7.9 | Submit date:2021/09/17
Cell Death  Danshen  Noptosis  Nqo1  
2-Methoxy-6-acetyl-7-methyljuglone (MAM) induced programmed necrosis in glioblastoma by targeting NAD(P)H: Quinone oxidoreductase 1 (NQO1) Journal article
Yu, Jie, Zhong, Bingling, Jin, Long, Hou, Ying, Ai, Nana, Ge, Wei, Li, Luoxiang, Liu, Shuqin, Lu, Jin Jian, Chen, Xiuping. 2-Methoxy-6-acetyl-7-methyljuglone (MAM) induced programmed necrosis in glioblastoma by targeting NAD(P)H: Quinone oxidoreductase 1 (NQO1)[J]. Free Radical Biology and Medicine, 2020, 152, 336-347.
Authors:  Yu, Jie;  Zhong, Bingling;  Jin, Long;  Hou, Ying;  Ai, Nana; et al.
Favorite | TC[WOS]:26 TC[Scopus]:27  IF:7.1/7.9 | Submit date:2021/09/17
Mam  Glioblastoma  Programmed Necrosis  Nqo1  
2-甲氧基-6-乙酰基-7-甲基胡桃酮的应用 Patent
专利类型: 发明专利 Invention, 专利号: CN110772503A, 申请日期: 2019-10-11,
Authors:  陈修平;  葛伟;  余洁;  钟冰玲
Favorite |  | Submit date:2022/05/21
Nqo1  
NQO1 dependent non-canonical necroptosis mediated by ROS and RIP1/RIP3 in parallel in glioma cancer cells Conference paper
Yu, J., Wu, X.X., Wang, C.X., Gao, H.W., Sun, W., Lu, J., Chen, X. P.. NQO1 dependent non-canonical necroptosis mediated by ROS and RIP1/RIP3 in parallel in glioma cancer cells[C], 2018.
Authors:  Yu, J.;  Wu, X.X.;  Wang, C.X.;  Gao, H.W.;  Sun, W.; et al.
Favorite |  | Submit date:2022/08/26
MAM  glioblastomas  non-canonical necroptosis  NQO1  
An NQO1 dependent ROS and RIP1/RIP3 mediated necroptosis induced in glioma cancer cells by a natural product, 2-Methoxy-6-acetyl-7-methyljuglone (MAM) Conference paper
Yu, J., Li, Z.W., Hou, Y., Yuan, R.Y.K., Lu, J., Chen, X. P.. An NQO1 dependent ROS and RIP1/RIP3 mediated necroptosis induced in glioma cancer cells by a natural product, 2-Methoxy-6-acetyl-7-methyljuglone (MAM)[C], 2017.
Authors:  Yu, J.;  Li, Z.W.;  Hou, Y.;  Yuan, R.Y.K.;  Lu, J.; et al.
Favorite |  | Submit date:2022/08/26
MAM  necroptosis  NQO1  ROS  RIP1/RIP3